drugset / Trial / NCT00497757

Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion

NCT00497757 ↗

Phase 1/2 Completed 62 enrolled Suzanne T. Ildstad
NaSingle-groupOpen-labelTreatment

Summary

The goal of this research study is to establish chimerism and avoid graft-versus-host disease in patients who need a heart transplant.

Timeline

Start
2003-07
Primary completion
2011-11-07
Completion
2016-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject enriched hematopoetic stem cell Cell therapy — —

Indications

No indication recorded.